T104	ZeroArticleNP 20 26	tablet
T105	DefiniteNP 124 167	the dihydropyridine calcium channel blocker
T106	IndefiniteNP 82 120	an extended release tablet dosage form
T107	ZeroArticleNP 269 309	dihydropyridine calcium channel blockers
T108	DefiniteNP 649 657	the time
T109	ZeroArticleNP 611 642	calcium channel blocker therapy
T110	DefiniteNP 678 691	The mechanism
T111	DemonstrativeNP 695 706	this effect
T112	DefiniteNP 816 824	the time
T113	DefiniteNP 1070 1096	the initial administration
T114	IndefiniteNP 964 982	other vasodilators
T115	ZeroArticleNP 1206 1256	medications that are known to lower blood pressure
T116	DefiniteNP 1284 1306	the hypotensive effect
T117	DefiniteNP 1488 1496	the time
T118	DemonstrativeNP 1419 1434	These responses
T119	ZeroArticleNP 1631 1661	NYHA Class II-IV heart failure
T120	IndefiniteNP 1941 1955	a beta-blocker
T121	ZeroArticleNP 1924 1935	combination
T122	PersonalPronoun 2085 2087	it
T123	DefiniteNP 2042 2051	the liver
T124	DemonstrativeNP 2125 2136	times those
T125	IndefiniteNP 2302 2328	an extended release tablet
T126	ZeroArticleNP 2360 2367	Tablets
T127	IndefiniteNP 2435 2451	an empty stomach
T128	IndefiniteNP 2484 2490	a meal
T129	DefiniteNP 2558 2577	the bioavailability
T130	ZeroArticleNP 2603 2648	dihydropyridine type calcium channel blockers
T131	DemonstrativeNP 2683 2695	This product
T132	DefiniteNP 2846 2867	the overall incidence
T133	PersonalPronoun 2948 2950	it
T134	DefiniteNP 2917 2939	the general population
T135	DefiniteNP 3078 3096	the interpretation
T136	IndefiniteNP 3138 3158	A 30 to 45% increase
T137	DistributivePronoun 3410 3416	either
T138	DistributiveNP 3410 3426	either histamine
T139	DistributiveNP 3410 3449	either histamine H2 receptor antagonist
T140	ZeroArticleNP 3466 3483	CYP3A4 inhibitors
T141	ZeroArticleNP 3488 3496	inducers
T142	IndefiniteNP 3562 3579	any known inducer
T143	ZeroArticleNP 3507 3516	substrate
T144	ZeroArticleNP 3583 3592	inhibitor
T145	DefiniteNP 3743 3780	the nisoldipine plasma concentrations
T146	IndefiniteNP 3669 3689	a dose bioequivalent
T147	ZeroArticleNP 3693 3712	34 mg SULAR tablets
T148	ZeroArticleNP 3868 3904	alternative antihypertensive therapy
T149	DefiniteNP 4076 4099	the heart rate increase
T150	DefiniteNP 4159 4184	The blood pressure effect
T151	DefiniteNP 4328 4347	the bioavailability
T152	DefiniteNP 4385 4407	the peak concentration
T153	PossessivePronoun 4551 4576	its clinical significance
T154	DemonstrativeNP 4495 4511	This interaction
T155	DefiniteNP 4868 4879	the maximum
T156	DefiniteNP 5022 5030	the MRHD
T157	IndefiniteNP 4913 4926	a mg/m2 basis
T158	IndefiniteNP 5034 5047	a mg/m2 basis
T159	DefiniteNP 5285 5305	the historical range
T160	IndefiniteNP 5131 5142	a mean dose
T161	IndefiniteNP 5207 5220	a mg/m2 basis
T162	IndefiniteNP 5223 5245	an increased frequency
T163	DefiniteNP 5487 5500	the Ames test
T164	DefiniteNP 5505 5524	the CHO/HGRPT assay
T165	IndefiniteNP 5444 5453	a battery
T166	DefiniteNP 5718 5726	the MRHD
T167	IndefiniteNP 5730 5743	a mg/m2 basis
T168	DefiniteNP 6263 6271	the MRHD
T169	IndefiniteNP 6289 6302	a mg/m2 basis
T170	DemonstrativeNP 6211 6222	These doses
T171	DefiniteNP 6419 6427	the MRHD
T172	IndefiniteNP 6380 6386	a dose
T173	IndefiniteNP 6445 6458	a mg/m2 basis
T174	DistributivePronoun 6498 6502	both
T175	DefiniteNP 6566 6590	the only surviving fetus
T176	DefiniteNP 6676 6684	the MRHD
T177	DefiniteNP 6811 6826	the same strain
T178	IndefiniteNP 6463 6470	a study
T179	IndefiniteNP 6596 6603	a group
T180	IndefiniteNP 6615 6630	a maternal dose
T181	IndefiniteNP 6702 6715	a mg/m2 basis
T182	DefiniteNP 6939 6960	the potential benefit
T183	DefiniteNP 6971 6989	the potential risk
T184	DefiniteNP 6993 7002	the fetus
T185	PersonalPronoun 7022 7024	It
T186	DefiniteNP 7227 7241	the importance
T187	DefiniteNP 7245 7253	the drug
T188	DefiniteNP 7257 7267	the mother
T189	IndefiniteNP 7132 7142	a decision
T190	ZeroArticleNP 7093 7103	many drugs
T191	PersonalPronoun 7492 7496	they
T192	DefiniteNP 7627 7638	the elderly
T193	DefiniteNP 7837 7848	the low end
T194	DefiniteNP 7852 7868	the dosing range
T195	DefiniteNP 7881 7902	the greater frequency
T196	IndefiniteNP 7778 7796	an elderly patient
T197	IndefiniteNP 7982 8000	other drug therapy
T198	DefiniteNP 8030 8040	The dosage
T199	DistributiveNP 8070 8082	each patient
T200	ZeroArticleNP 8092 8099	Therapy
T201	DefiniteNP 8350 8357	the 8.5
T202	ZeroArticleNP 8505 8514	diuretics
T203	ZeroArticleNP 8516 8530	ACE inhibitors
T204	ZeroArticleNP 8536 8556	beta-blocking agents
T205	PossessivePronoun 8690 8710	Their blood pressure
T206	IndefiniteNP 8746 8767	any dosage adjustment
T207	IndefiniteNP 8769 8784	A starting dose
T208	DemonstrativeNP 8830 8850	these patient groups
T209	ZeroArticleNP 8852 8865	SULAR tablets
T210	IndefiniteNP 8933 8949	an empty stomach
T211	IndefiniteNP 8982 8988	a meal
T212	ZeroArticleNP 8991 9010	Grapefruit products
T213	IndefiniteNP 9063 9094	an extended release dosage form
T214	ZeroArticleNP 9099 9106	tablets
T1	Drug_Class 1206 1256	medications that are known to lower blood pressure
T2	Drug 946 957	nisoldipine
T4	Drug_Class 970 982	vasodilators
T5	Substance 2493 2509	Grapefruit juice
T7	Drug 2581 2592	nisoldipine
T8	Drug_Class 2603 2648	dihydropyridine type calcium channel blockers
T9	Drug 3238 3248	cimetidine
T10	Drug 3178 3189	nisoldipine
T17	Drug 3551 3556	SULAR
T19	Drug 3654 3663	phenytoin
T21	Drug 3747 3758	nisoldipine
T23	Drug 3825 3830	SULAR
T24	Drug 3836 3845	phenytoin
T26	Drug 4053 4064	Propranolol
T27	Drug 4128 4157	immediate release nisoldipine
T29	Drug 4188 4193	SULAR
T30	Drug 4230 4238	atenolol
T32	Drug 4294 4303	Quinidine
T34	Drug 4357 4368	nisoldipine
T35	Drug 4409 4438	Immediate release nisoldipine
T37	Drug 4456 4465	quinidine
T38	Substance 8991 9010	Grapefruit products
T40	Drug 8908 8913	SULAR
T13	Drug_Class 3572 3579	inducer
T14	Drug_Class 3583 3592	inhibitor
T41	Drug_Class 285 309	calcium channel blockers
T42	Drug_Class 144 167	calcium channel blocker
T43	Drug_Class 611 634	calcium channel blocker
T44	Drug_Class 8516 8530	ACE inhibitors
T45	Drug_Class 8536 8556	beta-blocking agents
T46	Drug_Class 3466 3483	CYP3A4 inhibitors
T47	Drug_Class 3880 3904	antihypertensive therapy
T48	Drug_Class 4268 4292	antihypertensive therapy
T49	Drug 4666 4673	digoxin
T50	Drug_Class 8505 8514	diuretics
T51	Drug 4005 4016	propranolol
T52	Drug_Class 3980 3993	beta-blockers
T53	Drug 2996 3003	aspirin
T54	Drug 4654 4662	warfarin
T55	Drug_Class 1943 1955	beta-blocker
T56	Drug 7 18	nisoldipine
T57	Drug 66 77	nisoldipine
T58	Drug 168 179	nisoldipine
T59	Drug 843 854	nisoldipine
T60	Drug 1602 1613	nisoldipine
T61	Drug 2000 2011	nisoldipine
T62	Drug 3335 3346	nisoldipine
T63	Drug 3964 3975	nisoldipine
T64	Drug 4638 4649	nisoldipine
T65	Drug 4756 4767	nisoldipine
T66	Drug 5095 5106	nisoldipine
T67	Drug 5153 5164	nisoldipine
T68	Drug 5404 5415	Nisoldipine
T69	Drug 5745 5756	nisoldipine
T70	Drug 5808 5819	Nisoldipine
T71	Drug 5899 5910	Nisoldipine
T72	Drug 6641 6652	nisoldipine
T73	Drug 7046 7057	nisoldipine
T74	Drug 7395 7406	nisoldipine
T75	Drug 7734 7745	nisoldipine
T76	Drug 8677 8688	nisoldipine
T77	Drug 0 5	SULAR
T78	Drug 59 64	SULAR
T79	Drug 201 206	SULAR
T80	Drug 758 763	SULAR
T81	Drug 1114 1119	SULAR
T82	Drug 1310 1315	SULAR
T83	Drug 1722 1727	SULAR
T84	Drug 1834 1839	SULAR
T85	Drug 2149 2154	SULAR
T86	Drug 2293 2298	SULAR
T87	Drug 2410 2415	SULAR
T88	Drug 2675 2680	SULAR
T89	Drug 3041 3046	SULAR
T90	Drug 3498 3503	SULAR
T91	Drug 3699 3704	SULAR
T92	Drug 6897 6902	SULAR
T93	Drug 7200 7205	SULAR
T94	Drug 8044 8049	SULAR
T95	Drug 8473 8478	SULAR
T96	Drug 8852 8857	SULAR
T97	Drug 9054 9059	SULAR
T98	Drug 3995 4003	atenolol
T99	Drug 3269 3279	Ranitidine
T215	SPAN 7423 7441	sufficient numbers
T216	SPAN 8558 8566	Patients
R11	Appositive Attribute:T105 Head:T58
R12	PredicateNominative Attribute:T106 Head:T78
R13	PredicateNominative Attribute:T125 Head:T86
R14	PredicateNominative Attribute:T143 Head:T90
R15	Anaphora Anaphor:T122 Antecedent:T61
R16	Anaphora Anaphor:T131 Antecedent:T88
R17	Anaphora Anaphor:T187 Antecedent:T93
